Proc. roy. Soc. Med. Volume 65 July 1972 Comment This man must have developed his immune deficiency disease in adult life. He appears to have severe defects in both humoral and cell-mediated immunity. One might infer from the poor lymphocyte survival in vitro that the etiology of this man's immune deficiency disease is based on a generalized lymphocyte disorder affecting all classes of lymphocytes. However, one probable correlate in vitro of cell-mediated immunity, namely the ability of lymphocytes to kill target cells in culture, appears to have remained intact.
The cause of his malabsorption state is not known but may have been related to the presence of Giardia lamblia in the bowel. His satisfactory progress contrasts with that seen in the combined immunity deficiency of infancy where the disease is almost always fatal.
Quinidine-induced Thrombocytopenia L J Libman' MRCP (for B I Hoffbrand DM MRCP) (Whittington Hospital, London N19) and K L G Goldsmith MRCP MRCPath (MRC Blood Group Reference Laboratory, London SWI) Miss L C, aged 78 History: In July 1971 developed a purpuric rash on the legs, forearms and tongue. The rash cleared spontaneously in seven days but one month later reappeared.
On her admission to hospital on 25.8.71 a history of multiple drug ingestion was obtained including phenobarbitone for Meniere's disease, phenylbutazone for low back pain, orphenadrine for night cramps, ergotamine tartrate, quinidine for occasional palpitations and cyclopenthiazide for mild ankle cedema. As a girl she had taken preparations containing quinine for colds, and has since had drinks containing quinine without ill effect.
On examination: Fit and afebrile. Widespread purpuric eruption on legs and arms with some purpuric lesions on the tongue and buccal mucosa. The lymph glands, liver and spleen were not palpable and thejoints were normal.
Investigations: Hb 104 g/100 ml, WBC 7,800 (normal differential), platelet count 2,000/mmn3; normochromic, normocytic blood film; ESR 1Prwnt address: University College Hospital, London WCIE 6AU 28 mm in 1 h (Westergren). Coombs test, LE latex test and antinuclear factor negative; bone marrow examination showed megakaryocytes in normal numbers but morphologically abnormal with no platelet formation seen.
Further progress: A diagnosis of drug-induced thrombocytopenia was made. All the previous therapy was withdrawn and prednisone orally 40 mg per day started. The platelet count rose rapidly to normal. Results of platelet antibody studies (K L G G) showed positive complement fixation test for incomplete platelet antibodies in the presence of quinidine and also in the presence of quinine. The patient was discharged with instructions not to take any of her previous medication. On the third and fourth days after this she took two tablets of quinidine for palpitations and two days later was readmitted with bleeding gums, haemorrhagic bullw in the mouth and a purpuric rash as before. The platelet count was again 2,000/mm3, becoming normal with steroids. Patient is now well and offsteroids.
Comment
The patient demonstrates the classical distribution of purpura due to quinidine-induced thrombocytopenia, approximately 50 cases being previously recorded. The thrombocytopenia is thought to be due to a drug hypersensitivity reaction as with sedormid purpura (Ackroyd 1964) . Although quinidine and quinine are closely related chemically, being optical isomers, when hypersensitivity develops it is almost always specific for one or the other drug both clinically and by tests in vitro. The present case is exceptional in that there are platelet antibodies in the presence of both drugs although only quinidine appears to produce thrombocytopenia. A patient reported by Bolton & Dameshek (1956) showed an identical clinical picture and laboratory findings. An antibody in the yglobulin fraction of the serum from a sensitive patient reacts with platelets, quinidine and complement to cause platelet lysis. The nature of the antigen is disputed. Quinidine may act as a hapten by combining with platelets. Shulman (1964) believes that the drug combines with a macromolecule in the plasma and the platelet is only a reacting surface. Another theory suggests that it is a metabolite of the drug which acts as the hapten (Levine 1965) .
